Add to ORKGObjectives: To compare the in vitro and in vivo activities of a 4:1 (w/w) fosfomycin/tobramycin combi-nation (FTI) with those of fosfomycin and tobramycin alone against cystic fibrosis (CF) and non-CF bronchiectasis pathogens
Background: Inhaled antibiotics have been incorporated into contemporary European and British guidel...
AbstractEarly studies of the use of antibiotics in patients with cystic fibrosis suggested that they...
Tobramycin and amikacin resulted in comparable antimicrobial activity in serum and sputum of patient...
AbstractBackgroundThere is a need for new antibiotics or combination of antibiotics that possess act...
There is a need for new antibiotics or combination of antibiotics that possess activity against incr...
Antimicrobial therapy has been a major contributor to the increased life expectancy of CF patients s...
<div><p>Although antibiotics from different classes are frequently prescribed in combination to prev...
Respiratory disease is the main cause of morbidity and mortality in patients with cystic fibrosis (C...
AbstractThe infection of the airways of cystic fibrosis patients by Pseudomonas aeruginosa is a comp...
Chronic biofilm formation by Pseudomonas aeruginosa in cystic fibrosis (CF) lungs is a major cause o...
Pseudomonas aeruginosa and Burkholderia cepacia are the major pathogens that colonize the airway sur...
Therapies shown to be effective in cystic fibrosis are often provided to patients with bronchiectasi...
The antibacterial activity of fosfomycin-tobramycin combination was studied by time-kill assay in ei...
<p>In patients with cystic flbrosis, lower respiratory tract infections are characterized by a stead...
Background: Inhaled antibiotics have been incorporated into contemporary European and British guidel...
Background: Inhaled antibiotics have been incorporated into contemporary European and British guidel...
AbstractEarly studies of the use of antibiotics in patients with cystic fibrosis suggested that they...
Tobramycin and amikacin resulted in comparable antimicrobial activity in serum and sputum of patient...
AbstractBackgroundThere is a need for new antibiotics or combination of antibiotics that possess act...
There is a need for new antibiotics or combination of antibiotics that possess activity against incr...
Antimicrobial therapy has been a major contributor to the increased life expectancy of CF patients s...
<div><p>Although antibiotics from different classes are frequently prescribed in combination to prev...
Respiratory disease is the main cause of morbidity and mortality in patients with cystic fibrosis (C...
AbstractThe infection of the airways of cystic fibrosis patients by Pseudomonas aeruginosa is a comp...
Chronic biofilm formation by Pseudomonas aeruginosa in cystic fibrosis (CF) lungs is a major cause o...
Pseudomonas aeruginosa and Burkholderia cepacia are the major pathogens that colonize the airway sur...
Therapies shown to be effective in cystic fibrosis are often provided to patients with bronchiectasi...
The antibacterial activity of fosfomycin-tobramycin combination was studied by time-kill assay in ei...
<p>In patients with cystic flbrosis, lower respiratory tract infections are characterized by a stead...
Background: Inhaled antibiotics have been incorporated into contemporary European and British guidel...
Background: Inhaled antibiotics have been incorporated into contemporary European and British guidel...
AbstractEarly studies of the use of antibiotics in patients with cystic fibrosis suggested that they...
Tobramycin and amikacin resulted in comparable antimicrobial activity in serum and sputum of patient...